Rocket Pharmaceuticals, Inc. (RCKT)
3.435
-0.06
(-1.86%)
USD |
NASDAQ |
Sep 18, 12:54
Rocket Pharmaceuticals Market Cap : 376.27M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 17, 2026 | 383.39M |
| September 16, 2026 | 381.20M |
| September 15, 2026 | 373.53M |
| September 14, 2026 | 375.72M |
| September 11, 2026 | 366.96M |
| September 10, 2026 | 381.20M |
| September 09, 2026 | 397.63M |
| September 08, 2026 | 406.39M |
| September 04, 2026 | 422.82M |
| September 03, 2026 | 415.15M |
| September 02, 2026 | 422.82M |
| September 01, 2026 | 408.58M |
| August 31, 2026 | 407.49M |
| August 28, 2026 | 422.82M |
| August 27, 2026 | 396.53M |
| August 26, 2026 | 400.91M |
| August 25, 2026 | 414.06M |
| August 24, 2026 | 386.67M |
| August 21, 2026 | 384.48M |
| August 20, 2026 | 381.20M |
| August 19, 2026 | 399.82M |
| August 18, 2026 | 365.86M |
| August 17, 2026 | 372.43M |
| August 14, 2026 | 380.10M |
| August 13, 2026 | 365.86M |
| Date | Value |
|---|---|
| August 12, 2026 | 373.53M |
| August 11, 2026 | 383.39M |
| August 10, 2026 | 398.72M |
| August 07, 2026 | 395.44M |
| August 06, 2026 | 387.77M |
| August 05, 2026 | 381.93M |
| August 04, 2026 | 375.39M |
| August 03, 2026 | 372.11M |
| July 31, 2026 | 339.37M |
| July 30, 2026 | 350.29M |
| July 29, 2026 | 342.65M |
| July 28, 2026 | 342.65M |
| July 27, 2026 | 354.65M |
| July 24, 2026 | 348.10M |
| July 23, 2026 | 357.93M |
| July 22, 2026 | 360.11M |
| July 21, 2026 | 371.02M |
| July 20, 2026 | 374.29M |
| July 17, 2026 | 375.39M |
| July 16, 2026 | 372.11M |
| July 15, 2026 | 398.30M |
| July 14, 2026 | 397.21M |
| July 13, 2026 | 405.94M |
| July 10, 2026 | 426.67M |
| July 09, 2026 | 457.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.497B |
| Oncolytics Biotech, Inc. | 95.97M |
| Sangamo Therapeutics, Inc. | 58.45M |
| Sarepta Therapeutics, Inc. | 2.105B |
| Anixa Biosciences, Inc. | 94.07M |
Market Cap Related Metrics
| Price to Book Value | 1.020 |
| Price | 3.435 |
| Earnings Yield | -5.24% |